Results 51 to 60 of about 2,720,585 (409)

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

open access: yesNew England Journal of Medicine, 1999
BACKGROUND AND METHODS The extent to which renal allotransplantation - as compared with long-term dialysis - improves survival among patients with end-stage renal disease is controversial, because those selected for transplantation may have a lower base ...
R. Wolfe   +7 more
semanticscholar   +1 more source

Predicting Kidney Transplant Survival using Multiple Feature Representations for HLAs [PDF]

open access: yesProceedings of the 19th International Conference on Artificial Intelligence in Medicine (2021) 51-60, 2021
Kidney transplantation can significantly enhance living standards for people suffering from end-stage renal disease. A significant factor that affects graft survival time (the time until the transplant fails and the patient requires another transplant) for kidney transplantation is the compatibility of the Human Leukocyte Antigens (HLAs) between the ...
arxiv  

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. [PDF]

open access: yes, 2017
Purpose T-cell-replete HLA-haploidentical donor hematopoietic transplantation using post-transplant cyclophosphamide was originally described using bone marrow (BM).
Al Malki, Monzr M   +23 more
core   +2 more sources

Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Organ Transplantation

open access: yesFrontiers in Immunology, 2022
Organ transplantation is the most preferred treatment option for end-stage organ diseases; however, allograft rejection is the major hurdle in successful long-term transplant survival.
Saeedeh Salehi   +5 more
doaj   +1 more source

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation

open access: yesNew England Journal of Medicine, 2017
Background Cytomegalovirus (CMV) infection remains a common complication after allogeneic hematopoietic‐cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–terminase complex.
F. Marty   +22 more
semanticscholar   +1 more source

GSH Attenuates Organ Injury and Improves Function after Transplantation of Fatty Livers [PDF]

open access: yes, 2010
Ischemia-reperfusion injury (IRI) is increased after transplantation of steatotic livers. Since those livers are increasingly used for transplantation, protective strategies must be developed. Reactive oxygen species (ROS) play a key role in hepatic IRI.
Angele, M. K.   +7 more
core   +1 more source

Bordetella hinzii Meningitis in Patient with History of Kidney Transplant, Virginia, USA

open access: yesEmerging Infectious Diseases, 2021
A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis.
Joseph Pechacek   +2 more
doaj   +1 more source

New Automatized Method of 3D Multiculture Viability Analysis Based on Confocal Imagery: Application to Islets and Mesenchymal Stem Cells Co-Encapsulation

open access: yesFrontiers in Endocrinology, 2018
Co-encapsulation of pancreatic islets with mesenchymal stem cells in a three-dimensional biomaterial’s structure is a promising technique to improve transplantation efficacy and to decrease immunosuppressant therapy.
Clovis Chabert   +21 more
doaj   +1 more source

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients

open access: yesFrontiers in Pharmacology, 2020
Tacrolimus is metabolized by CYP3A4 and CYP3A5 enzymes. Patients expressing CYP3A5 (in Caucasian patients about 15% of the population but more frequent in African Americans and Asians) have a dose requirement that is around 50% higher than non-expressers
Teun van Gelder   +6 more
doaj   +1 more source

Myeloablative Autologous Stem‐Cell Transplantation for Severe Scleroderma

open access: yesNew England Journal of Medicine, 2018
BACKGROUND Despite current therapies, diffuse cutaneous systemic sclerosis (scleroderma) often has a devastating outcome. We compared myeloablative CD34+ selected autologous hematopoietic stem‐cell transplantation with immunosuppression by means of 12 ...
K. Sullivan   +41 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy